Firalis Molecular Precision has emerged as France’s leading NGS service-provider, spearheading the genomics revolution in the country.
With a steadfast commitment to excellence, innovation, and precision, Firalis Molecular Precision has acquired Illumina’s groundbreaking sequencing technologies, including the NextSeq 500, NextSeq 2000, NovaSeq 6000 Dx, and the highly anticipated Novaseq X-Plus.
These technologies represent the pinnacle of genomics technology and enable Firalis Molecular Precision to deliver unparalleled precision, scalability, and efficiency to its esteemed clientele.